Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | A multimodal approach to Alzheimer’s disease

Marwan Sabbagh • 17 Jul 2017
AAIC 2017
Alzheimer’s Disease

Marwan Sabbagh, MD, from Barrow Neurological Institute, Phoenix, AZ spoke at the Biogen symposium at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK about the importance of non-pharmacological approaches in treating Alzheimer’s disease. He demonstrated the strength and effect of using non-pharmacological interventions and emphasises how physicians need to adopt a multimodal approach when devising management plans.

More from Marwan Sabbagh

What's next for intepirdine
1:29
What's next for intepirdine
Marwan Sabbagh • 17 Jul 2017
Intepirdine provides new hope for Alzheimer's disease
0:54
Intepirdine provides new hope for Alzheimer's disease
Marwan Sabbagh • 17 Jul 2017
Alzheimer's disease: from terminal to chronic
1:06
Alzheimer's disease: from terminal to chronic
Marwan Sabbagh • 17 Jul 2017
What can we be excited about in the world of Alzheimer's disease?
1:29
What can we be excited about in the world of Alzheimer's disease?
Marwan Sabbagh • 17 Jul 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals